Daniel G Welch is of Seagen Inc.. Currently has a direct ownership of 0 shares of SGEN, which is worth approximately $0. The most recent transaction as insider was on Dec 14, 2023, when has been sold 4,750 shares (Common Stock) at a price of $229.0 per share, resulting in proceeds of $1,087,750. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

DANIEL G WELCH Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 14 2023
SELL
Sale (or disposition) back to the issuer
$1,087,750 $229.0 p/Share
4,750 Reduced 100.0%
0 Common Stock
Aug 28 2023
SELL
Open market or private sale
$693,100 $209.08 p/Share
3,315 Reduced 32.79%
6,794 Common Stock
Aug 28 2023
BUY
Exercise of conversion of derivative security
$245,761 $135.63 p/Share
1,812 Added 15.2%
10,109 Common Stock
May 31 2023
BUY
Grant, award, or other acquisition
-
2,044 Added 19.77%
8,297 Common Stock
May 15 2023
SELL
Open market or private sale
$372,837 $200.02 p/Share
1,864 Reduced 22.96%
6,253 Common Stock
May 15 2023
BUY
Exercise of conversion of derivative security
$252,814 $135.63 p/Share
1,864 Added 18.68%
8,117 Common Stock
May 02 2023
SELL
Open market or private sale
$1,775,021 $200.07 p/Share
8,872 Reduced 58.66%
6,253 Common Stock
May 02 2023
BUY
Exercise of conversion of derivative security
$1,057,200 $124.07 p/Share
8,521 Added 45.84%
10,066 Common Stock
May 01 2023
SELL
Open market or private sale
$1,487,520 $200.07 p/Share
7,435 Reduced 52.96%
6,604 Common Stock
May 01 2023
BUY
Exercise of conversion of derivative security
$432,469 $60.57 p/Share
7,140 Added 44.54%
8,889 Common Stock
Apr 03 2023
SELL
Open market or private sale
$4,088,656 $201.66 p/Share
20,275 Reduced 83.01%
4,149 Common Stock
Apr 03 2023
BUY
Exercise of conversion of derivative security
$1,028,542 $58.69 p/Share
17,525 Added 71.43%
7,011 Common Stock
Mar 15 2023
SELL
Open market or private sale
$471,517 $200.05 p/Share
2,357 Reduced 25.46%
6,899 Common Stock
Mar 15 2023
BUY
Exercise of conversion of derivative security
$79,076 $38.82 p/Share
2,037 Added 18.04%
9,256 Common Stock
Mar 14 2023
SELL
Open market or private sale
$108,800 $200.0 p/Share
544 Reduced 4.02%
12,977 Common Stock
Mar 14 2023
BUY
Exercise of conversion of derivative security
$18,245 $38.82 p/Share
470 Added 3.38%
13,447 Common Stock
Mar 13 2023
SELL
Open market or private sale
$3,495,475 $201.19 p/Share
17,374 Reduced 70.65%
7,219 Common Stock
Mar 13 2023
BUY
Exercise of conversion of derivative security
$595,613 $39.66 p/Share
15,018 Added 39.46%
23,036 Common Stock
May 13 2022
BUY
Grant, award, or other acquisition
-
1,503 Added 13.48%
9,649 Common Stock
May 14 2021
BUY
Grant, award, or other acquisition
-
1,402 Added 3.24%
41,931 Common Stock
Nov 02 2020
SELL
Open market or private sale
$9,768,950 $166.28 p/Share
58,750 Reduced 55.37%
47,348 Common Stock
Nov 02 2020
BUY
Exercise of conversion of derivative security
$1,287,990 $26.02 p/Share
49,500 Added 41.05%
71,098 Common Stock

Also insider at

NUVB
Nuvation Bio Inc. Healthcare
RARE
Ultragenyx Pharmaceutical Inc. Healthcare
GPCR
Structure Therapeutics Inc.
PRTA
PROTHENA CORP PUBLIC LTD CO Healthcare
DGW

Daniel G Welch

Bothell, WA

Track Institutional and Insider Activities on SGEN

Follow Seagen Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGEN shares.

Notify only if

Insider Trading

Get notified when an Seagen Inc. insider buys or sells SGEN shares.

Notify only if

News

Receive news related to Seagen Inc.

Track Activities on SGEN